Screening for vancomycin intermediate--resistant Staphylococcus aureus among clinical isolates of MRSA

Sonavane, A.; De, A.; Mathur, M.
January 2007
Indian Journal of Medical Microbiology;Jan2007, Vol. 25 Issue 1, p79
Academic Journal
No abstract available.


Related Articles

  • Occurrence of vancomycin-intermediate-resistant Staphylococcus aureus in Japan. Yasuko Hososaka; Chie Yanagisawa; Yoshihito Otsuka; Zenzo Nagasawa; Taiji Nakae; Keisuke Sunakawa // Journal of Infection & Chemotherapy (Springer Science & Business;Apr2007, Vol. 13 Issue 2, p118 

    Abstract  The Clinical and Laboratory Standards Institute (CLSI) amended the criteria for vancomycin susceptibility and resistance of Staphylococcus aureus in 2006. The earlier criteria had established that S. aureus with minimum inhibitory concentrations (MICs) of vancomycin of...

  • Detection of Vancomycin Resistance among Enterococcus faecalis and Staphylococcus aureus. RENGARAJ, RAMYA; MARIAPPAN, SHANTHI; SEKAR, UMA; KAMALANADHAN, ARUNAGIRI // Journal of Clinical & Diagnostic Research;Feb2016, Vol. 10 Issue 2, p4 

    Introduction: Vancomycin remains the drug of choice for resistant gram positive infections caused by Enterococcus spp and Methicillin resistant Staphylococcus aureus (MRSA). Increased use of vancomycin has led to frank resistance and increase in MIC (MIC creep). Vancomycin intermediate...

  • INCREASED VANCOMYCIN MINIMUM INHIBITORY CONCENTRATION (MIC) AMONG MRSA ISOLATES IN A TERTIARY CARE HOSPITAL. K. B., Asha Pai; N. N., Sweetha; H., Sanjeev; R., Rekha; K. K., Vimal; H. R., Ganesh // Nitte University Journal of Health Science;Dec2013, Vol. 3 Issue 4, p10 

    Introduction : Methicillin Resistant Staphylococcus aureus (MRSA) is not only an important nosocomial pathogen but also an incipient community pathogen in many geographical areas. Recommended therapeutic agent for treatment of MRSA infections are glycopeptides, in particular vancomycin. The...

  • Evidence for a Continuum of Decreased Vancomycin Susceptibility in Unselected Staphylococcus aureus Clinical Isolates. Hussain, Farid M.; Boyle-Vavra, Susan; Shete, Priya B.; Daum, Robert S. // Journal of Infectious Diseases;9/1/2002, Vol. 186 Issue 5, p661 

    Some Staphylococcus aureus isolates have glycopeptide minimal inhibitory concentrations (MICs) in the susceptible range but have subpopulations that grow on ≤4 µg/mL vancomycin. Clinical laboratory methods for determining susceptibility have proven to be inadequate for detecting these...

  • Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen. Stryjewski, Martin E.; Corey, G. Ralph // Clinical Infectious Diseases;Jan2014, Vol. 58 Issue suppl_1, pS10 

    The horizontal transmission of methicillin resistance to Staphylococcus aureus (MRSA) in hospital and community settings, and growing prevalence of these strains, presents a significant clinical challenge to the management of serious infections worldwide. While infection control initiatives have...

  • Mechanisms of vancomycin resistance in Staphylococcus aureus. Gardete, Susana; Tomasz, Alexander // Journal of Clinical Investigation;Jul2014, Vol. 124 Issue 7, p2836 

    Vancomycin is a glycopeptide antibiotic used for the treatment o f Gram-positive bacterial infections. Traditionally, it has been used as a drug of last resort; however, clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) strains with decreased susceptibility to vancomycin...

  • A PROSPECTIVE STUDY OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) IN A TEACHING HOSPITAL OF RURAL SETUP. Rao, Bandaru Narasinga; Srinivas. B. // Journal of Pharmaceutical & Scientific Innovation;Mar/Apr2012, Vol. 1 Issue 2, p37 

    Methicillin Resistant Staphylococcus aureus (MRSA) is an important nosocomial pathogen. We report the prevalence and antimicrobial susceptibility pattern of MRSA in a Teaching Hospital of Rajivgandhi Institute of Medical Sciences (RIMS), Srikakulam, Andhra Pradesh, India. A total of 4840...

  • Study of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus isolated from clinical samples. Sharma, Prajna; Vishwanath, G. // Annals of Tropical Medicine & Public Health;May/Jun2012, Vol. 5 Issue 3, p178 

    Background: Staphylococcus aureus is one of the most commonly isolated organisms in nosocomial infections. While the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) continues to increase worldwide, there is a concern about an increase in vancomycin minimum inhibitory...

  • Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus: a multicentre study. Rajaduraipandi, K.; Mani, K. R.; Panneerselvam, K.; Mani, M.; Bhaskar, M.; Manikandan, P. // Indian Journal of Medical Microbiology;Jan2006, Vol. 24 Issue 1, p34 

    Purpose: Methicillin resistant Staphylococcus aureus (MRSA) is an important nosocomial pathogen. We report the prevalence and antibiotic susceptibility pattern of MRSA in major southern districts of Tamilnadu.Methods: A total of 7172 clinical specimens and 1725 carrier...

  • Accessory Gene Regulator Group II Polymorphism in Methicillin-Resistant Staphylococcus aureus Is Predictive of Failure of Vancomycin Therapy. Moise-Broder, Pamela A.; Sakoulas, George; Eliopoulos, George M.; Schentag, Jerome J.; Forrest, Alan; Moellering Jr., Robert C. // Clinical Infectious Diseases;6/15/2004, Vol. 38 Issue 12, p1700 

    We studied methicillin-resistant Staphylococcus aureus (MRSA) isolates to determine if the group II polymorphism at the accessory gene regulator (agr) locus demonstrated any relationship with the clinical efficacy of vancomycin. One hundred twenty-two MRSA isolates from 87 patients treated with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics